Contrasting properties of VEGF165 and VEGF165b splicing isoforms on glomerular water permeability in transgenic mice and complementary rescue of the phenotype

被引：0
|
作者：
Oltean, Sebastian [1 ]
Ferguson, Joanne [1 ]
Qiu, Yan [1 ]
Salmon, Andrew H. [1 ]
Quaggin, Susan [2 ]
Harper, Steve J. [1 ]
Bates, David O. [1 ]
机构：
[1] Univ Bristol, Bristol, Avon, England
[2] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
来源：
FASEB JOURNAL | 2010年 / 24卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 29 条
  • [21] The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice
    E S Rennel
    E Waine
    H Guan
    Y Schüler
    W Leenders
    J Woolard
    M Sugiono
    D Gillatt
    E S Kleinerman
    D O Bates
    S J Harper
    British Journal of Cancer, 2008, 98 : 1250 - 1257
  • [22] Effects of gestational diabetes mellitus on vascular permeability and angiogenesis in the human placenta -: Role of VEGF165B
    Leach, L.
    Reeve, K. S.
    Garrioch, M. A. V.
    Buckley, D. A.
    Bates, D. O.
    PLACENTA, 2007, 28 (8-9) : A22 - A22
  • [23] Impaired vascular permeability regulation caused by the VEGF165b splice variant in pre-eclampsia
    Bills, V. L.
    Salmon, A. H.
    Harper, S. J.
    Overton, T. G.
    Neal, C. R.
    Jeffery, B.
    Soothill, P. W.
    Bates, D. O.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2011, 118 (10) : 1253 - 1261
  • [24] Recombinant human VEGF165b protein is an effective anti-cancer agent in mice
    Rennel, Emma S.
    Hamdollah-Zadeh, Maryam A.
    Wheatley, Edward R.
    Magnussen, Anette
    Schueler, Yvonne
    Kelly, Sara P.
    Finucane, Ciara
    Ellison, David
    Cebe-Suarez, Stephanie
    Ballmer-Hofer, Kurt
    Mather, Stephen
    Stewart, Lorna
    Bates, David O.
    Harper, Steven J.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (13) : 1883 - 1894
  • [25] Evaluation of mRNA and protein expression of VEGFxxx and VEGF165b isoforms in head and neck squamous cells carcinoma
    Biselli-Chicote, Patricia M.
    Marucci, Gustavo H.
    Castro, Rodrigo
    Cunha, Bianca R.
    Maniglia, Jose V.
    Neto, Dalisio S.
    Gois-Filho, Jose F.
    Fukuyama, Erica E.
    Pavarino, Erika C.
    Goloni-Bertollo, Eny M.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 : S28 - S28
  • [26] VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma:: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
    Varey, A. H. R.
    Rennel, E. S.
    Qiu, Y.
    Bevan, H. S.
    Perrin, R. M.
    Raffy, S.
    Dixon, A. R.
    Paraskeva, C.
    Zaccheo, O.
    Hassan, A. B.
    Harper, S. J.
    Bates, D. O.
    BRITISH JOURNAL OF CANCER, 2008, 98 (08) : 1366 - 1379
  • [27] VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
    A H R Varey
    E S Rennel
    Y Qiu
    H S Bevan
    R M Perrin
    S Raffy
    A R Dixon
    C Paraskeva
    O Zaccheo
    A B Hassan
    S J Harper
    D O Bates
    British Journal of Cancer, 2008, 98 : 1366 - 1379
  • [28] VEGF165b and its mutant demonstrate immunomodulatory, not merely anti-angiogenic functions, in tumor-bearing mice
    Zhang Huiyong
    Xia Wenjiao
    Liang Chen
    Wang Xiaoyin
    Zhi Lingtong
    Guo Changjiang
    Niu Zhiyuan
    Zhu Wuling
    MOLECULAR IMMUNOLOGY, 2020, 122 : 132 - 140
  • [29] WT1TMT396/+ MICE WITH MURINE DENYS-DRASH SYNDROME HAVE REDUCED VEGF165B PROTEIN WITH ADVANCING DISEASE BUT NORMAL LEVELS PRIOR TO THE ONSET OF DISEASE
    Wroe, C.
    White, K. E.
    Woolard, J.
    Miles, C. G.
    PEDIATRIC NEPHROLOGY, 2009, 24 (09) : 1791 - 1791
123